Clinical Study of the Safety and Pharmacokinetics of the Drug Fluorothiazinone, a Concentrate for Solution Preparation for Infusion.

Conditions

• Safety and Pharmacokinetics

Interventions

• DRUG: ¼ of the full (target) dose (solution, 5 ml)
• DRUG: ½ of the full (target) dose (solution, 10 ml)
• DRUG: full dose (solution, 20 ml)
• DRUG: 1 ½ of the full (target) dose (solution, 30 ml)
• DRUG: 2 full doses (solution, 40 ml)
• DRUG: course administration of the selected dose
• OTHER: Placebo

Sponsor

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation